Based on the Trulieve Cannabis Corp stock forecast from 1 analysts, the average analyst target price for Trulieve Cannabis Corp is CAD 21.00 over the next 12 months. Trulieve Cannabis Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Trulieve Cannabis Corp is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Trulieve Cannabis Corp’s stock price was CAD 6.95. Trulieve Cannabis Corp’s stock price has changed by +1.76% over the past week, -21.65% over the past month and +8.93% over the last year.
No recent analyst target price found for Trulieve Cannabis Corp
No recent average analyst rating found for Trulieve Cannabis Corp
Company Overview Trulieve Cannabis Corp
Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It also operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida. Read Less
Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, cr...Read More
Frequently Asked Questions About Trulieve Cannabis Corp (TRUL:CA) Stock
Based on ratings from 1 analysts Trulieve Cannabis Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on TRUL:CA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for TRUL:CA is CAD 21.00 over the next 12 months. The maximum analyst target price is CAD 21 while the minimum anlayst target price is CAD 21.
TRUL:CA stock's Price/Earning ratio is 121.35.
Our analysis grades TRUL:CA stock's Price / Earning ratio at F. This means that TRUL:CA stock's Price/Earning ratio is above 95% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the CNSX exchange.
Based on this TRUL:CA may be a overvalued for its sector.
The last closing price of TRUL:CA's stock was CAD 6.95.
The most recent market capitalization for TRUL:CA is CAD 1.46B.
Based on targets from 1 analysts, the average taret price for TRUL:CA is projected at CAD 21.00 over the next 12 months.
This means that TRUL:CA's stock price may go up by +202.16% over the next 12 months.
We can't find any ETFs which contains Trulieve Cannabis Corp's stock.
As per our most recent records Trulieve Cannabis Corp has 5,400 Employees.
Trulieve Cannabis Corp's registered address is 6749 Ben Bostic Road, Quincy, FL, United States, 32351.
You can get more information about it from Trulieve Cannabis Corp's website at https://www.trulieve.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Trulieve Cannabis Corp (TRUL:CA) Stock
Based on ratings from 1 analysts Trulieve Cannabis Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on TRUL:CA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for TRUL:CA is CAD 21.00 over the next 12 months. The maximum analyst target price is CAD 21 while the minimum anlayst target price is CAD 21.
TRUL:CA stock's Price/Earning ratio is 121.35.
Our analysis grades TRUL:CA stock's Price / Earning ratio at F. This means that TRUL:CA stock's Price/Earning ratio is above 95% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the CNSX exchange.
Based on this TRUL:CA may be a overvalued for its sector.
The last closing price of TRUL:CA's stock was CAD 6.95.
The most recent market capitalization for TRUL:CA is CAD 1.46B.
Based on targets from 1 analysts, the average taret price for TRUL:CA is projected at CAD 21.00 over the next 12 months.
This means that TRUL:CA's stock price may go up by +202.16% over the next 12 months.
We can't find any ETFs which contains Trulieve Cannabis Corp's stock.
As per our most recent records Trulieve Cannabis Corp has 5,400 Employees.
Trulieve Cannabis Corp's registered address is 6749 Ben Bostic Road, Quincy, FL, United States, 32351.
You can get more information about it from Trulieve Cannabis Corp's website at https://www.trulieve.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TRUL:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
